MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited Operating Income 2011-2026 | VNRX
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -27 M | -36 M | -31.8 M | -28.3 M | -21.2 M | -16 M | -17.9 M | -14.7 M | -12.4 M | -10 M | -5.95 M | -4.58 M | -4.08 M | -2.61 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.61 M | -36 M | -16.6 M |
Quarterly Operating Income VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.1 M | -6.3 M | -5.52 M | - | -5.87 M | -6.99 M | -8.38 M | - | -8.65 M | -9.55 M | -9.05 M | - | -7.99 M | -8.1 M | -7.68 M | - | -7.56 M | -5.9 M | -6.09 M | - | -4.5 M | -5.21 M | -5.87 M | - | -4.18 M | -4.15 M | -3.99 M | - | -4.45 M | -4.57 M | -4.63 M | - | -3.88 M | -3.44 M | -3.34 M | - | -3.48 M | -2.98 M | -2.49 M | - | -2.97 M | -2.02 M | -2.35 M | - | -1.76 M | -1.05 M | -1.24 M | - | -926 K | -1.05 M | -908 K | - | -873 K | -931 K | -802 K | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -802 K | -9.55 M | -4.45 M |
Operating Income of other stocks in the Diagnostics research industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-46 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
-5 M | $ 22.96 | -0.56 % | $ 99.4 M |  Israel |
|
Akumin
AKU
|
-28.1 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-14 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Danaher Corporation
DHR
|
4.86 B | $ 237.64 | 1.12 % | $ 174 B | USA |
 |
DarioHealth Corp.
DRIO
|
-56.2 M | $ 12.15 | -5.81 % | $ 345 M | Israel |
 |
Burning Rock Biotech Limited
BNR
|
-797 M | $ 23.25 | -0.66 % | $ 250 M |  China |
 |
DexCom
DXCM
|
598 M | $ 66.95 | -2.16 % | $ 25.8 B | USA |
 |
Biocept
BIOC
|
-32 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-104 M | $ 1.59 | -0.94 % | $ 2.02 M | USA |
 |
Chembio Diagnostics
CEMI
|
-23.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-25.9 M | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
-42.7 M | $ 6.12 | - | $ 180 M | USA |
 |
IQVIA Holdings
IQV
|
2.2 B | $ 243.33 | 0.06 % | $ 44.1 B | USA |
 |
Castle Biosciences
CSTL
|
8.67 M | $ 39.59 | -0.76 % | $ 1.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
609 M | - | - | $ 399 M | China |
 |
DermTech
DMTK
|
-104 M | - | -11.32 % | $ 2.94 M | USA |
 |
Genetron Holdings Limited
GTH
|
-518 M | - | 0.12 % | $ 80.1 M | China |
 |
Natera
NTRA
|
-541 M | $ 234.65 | -2.05 % | $ 23.1 B | USA |
 |
CareDx, Inc
CDNA
|
-203 M | $ 17.02 | -1.16 % | $ 915 M | USA |
 |
Celcuity
CELC
|
-113 M | $ 107.43 | 2.63 % | $ 4.24 B | USA |
 |
Enzo Biochem
ENZ
|
-12.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Pacific Biosciences of California
PACB
|
-334 M | $ 1.95 | -4.66 % | $ 495 M | USA |
 |
Anixa Biosciences
ANIX
|
-13.8 M | $ 3.41 | -0.29 % | $ 109 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-876 M | $ 102.13 | 0.34 % | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
-73.9 M | $ 27.84 | -0.2 % | $ 842 M | USA |
 |
QIAGEN N.V.
QGEN
|
97.7 M | $ 48.32 | -0.27 % | $ 10.8 B |  Niderland |
 |
RadNet
RDNT
|
105 M | $ 77.42 | -1.22 % | $ 5.65 B | USA |
 |
Guardant Health
GH
|
-444 M | $ 110.18 | 1.32 % | $ 13.5 B | USA |
 |
Aspira Women's Health
AWH
|
-32.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
-20.3 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-20.8 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-833 M | $ 141.01 | -3.31 % | $ 22.4 B | USA |
 |
Charles River Laboratories International
CRL
|
227 M | $ 220.64 | 2.38 % | $ 11.3 B | USA |
 |
Thermo Fisher Scientific
TMO
|
7.34 B | $ 620.69 | 2.34 % | $ 237 B | USA |
 |
Trinity Biotech plc
TRIB
|
6.62 M | $ 0.73 | -1.13 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
-136 M | $ 35.58 | 2.42 % | $ 2.13 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.35 B | $ 175.1 | -1.49 % | $ 19.4 B | USA |
|
Biodesix
BDSX
|
-34.5 M | $ 5.46 | -2.15 % | $ 708 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.09 B | $ 252.61 | -0.81 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
1.1 B | $ 183.13 | -2.7 % | $ 15.1 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.13 B | $ 715.47 | 0.43 % | $ 59 B | USA |
 |
Lantheus Holdings
LNTH
|
457 M | $ 67.98 | 0.19 % | $ 4.7 B | USA |
 |
Agilent Technologies
A
|
1.35 B | $ 148.92 | 2.17 % | $ 45.3 B | USA |
 |
Biomerica
BMRA
|
-5.14 M | $ 2.75 | -4.84 % | $ 6.32 M | USA |
 |
Bioventus
BVS
|
-81.7 M | $ 8.02 | 0.25 % | $ 502 M | USA |